JAMA Network Open
Original Investigation
Pediatrics
May 24, 2023
Ho Geol Woo, MD, PhD; Sangil Park, MD; Hyunju Yon, MD; Seung Won Lee, MD, PhD; Ai Koyanagi, MD, PhD; Louis Jacob, PhD; Lee Smith, PhD; Wonyoung Cho, PhD; Chanyang Min, PhD; Jinseok Lee, PhD; Hayeon Lee, MS; Rosie Kwon, MS; Guillaume Fond, PhD; Laurent Boyer, PhD; Yoonie Yoonjung Joo, PhD; Yong Sung Choi, MD, PhD; Seung-Geun Yeo, MD, PhD; Sang Youl Rhee, MD, PhD; Jae Il Shin, MD, PhD; Dong Keon Yon, MD
open access
JAMA Netw Open. 2023; 6(5):e2314838. doi: 10.1001/jamanetworkopen.2023.14838
This survey study of more than 1 million Korean adolescents examines whether the observed sadness and suicidality in the early to middle periods of the COVID-19 pandemic differed from the expected level and investigates changes in risk factors for sadness and suicidality.
JAMA Network Open
Research Letter
Public Health
October 27, 2022
Karel Kostev, PhD; Susanne Abeler; Ai Koyanagi, MD, PhD; Josep Maria Haro, MD, PhD; Lee Smith, PhD; Louis Jacob, MD, PhD
open access
JAMA Netw Open. 2022; 5(10):e2240032. doi: 10.1001/jamanetworkopen.2022.40032
This cross-sectional study investigates sales of over-the-counter iodine-containing drugs in 20 European countries between January 2021 and March 2022.
JAMA Oncology
Original Investigation
October 1, 2019
Guillaume Assié, MD, PhD; Anne Jouinot, MD; Martin Fassnacht, MD, PhD; Rossella Libé, MD; Simon Garinet, PharmD; Louis Jacob, BS; Nadim Hamzaoui, MD; Mario Neou, MS; Julien Sakat, MD; Bruno de La Villéon, MD; Karine Perlemoine, BS; Bruno Ragazzon, PhD; Mathilde Sibony, MD; Frédérique Tissier, MD; Sébastien Gaujoux, MD, PhD; Bertrand Dousset, MD, PhD; Silviu Sbiera, MD, PhD; Cristina L. Ronchi, MD, PhD; Matthias Kroiss, MD, PhD; Esther Korpershoek, PhD; Ronald De Krijger, MD, PhD; Jens Waldmann, MD, PhD; Marcus Quinkler, MD, PhD; Magalie Haissaguerre, MD, PhD; Antoine Tabarin, MD, PhD; Olivier Chabre, MD, PhD; Michaela Luconi, MD, PhD; Massimo Mannelli, MD, PhD; Lionel Groussin, MD, PhD; Xavier Bertagna, MD, PhD; Eric Baudin, MD, PhD; Laurence Amar, MD, PhD; Joel Coste, MD, PhD; Felix Beuschlein, MD, PhD; Jérôme Bertherat, MD, PhD
free access
JAMA Oncol. 2019; 5(10):1440-1447. doi: 10.1001/jamaoncol.2019.1558
This biomarker analyss of patients with adrenocortical carcinoma compares the molecular classification for prognostic assessment of adrenocortical carcinoma with other known prognostic factors.
JAMA
Original Contribution
June 12, 2013
Mette Thomsen, MD; Truls Sylvan Ingebrigtsen, MD; Jacob Louis Marott, MSc; Morten Dahl, DMSc; Peter Lange, DMSc; Jørgen Vestbo, DMSc; Børge G. Nordestgaard, DMSc
free access
JAMA. 2013; 309(22):2353-2361. doi: 10.1001/jama.2013.5732
Among patients with chronic obstructive pulmonary disease (COPD), Thomsen and coauthors investigated whether elevated levels of inflammatory biomarkers were associated with an increased risk of having exacerbations. In an Editorial, Mador and Sethi discuss efforts to improve current therapies and develop new therapies for exacerbation reduction in COPD.
JAMA Ophthalmology
Article
September 1, 1988
Michael Quigley, MD; Jean-Louis Jacob, MD
Arch Ophthalmol. 1988; 106(9):1164-1165. doi: 10.1001/archopht.1988.01060140324011